TMPO-AS1

gene
On this page

Summary

TMPO-AS1 (TMPO antisense RNA 1, HGNC:44158) is a long non-coding RNA gene on chromosome 12q23.1.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:44158
Approved symbolTMPO-AS1
NameTMPO antisense RNA 1
Location12q23.1
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000257167
Ensembl biotypelncRNA
Entrez100128191
RNAcentralURS000075B992 — lncRNA, 3161 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 5 lncRNA

ENST00000546421, ENST00000548760, ENST00000733960, ENST00000733961, ENST00000733962

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000546421 — 3 exons

ExonStartEnd
ENSE000023597079851547798515897
ENSE000023739519851599198516210
ENSE000023873409851440098515390

Expression profiles

Bgee: expression breadth ubiquitous, 157 present calls, max score 80.65.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.8794 / max 107.3582, expressed in 1284 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1328311.7832845
1328290.7682373
1328320.7465450
1328270.7241354
1328280.6483367
1328300.2090113

Top tissues by expression

255 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047380.65silver quality
left testisUBERON:000453379.74gold quality
right testisUBERON:000453478.91gold quality
testisUBERON:000047378.14gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099177.95gold quality
ventricular zoneUBERON:000305373.83gold quality
ganglionic eminenceUBERON:000402372.17gold quality
bone marrow cellCL:000209272.06gold quality
monocyteCL:000057670.25gold quality
leukocyteCL:000073870.13gold quality
adult organismUBERON:000702369.68gold quality
stromal cell of endometriumCL:000225567.65gold quality
spermCL:000001967.32silver quality
cortical plateUBERON:000534366.69gold quality
granulocyteCL:000009466.38gold quality
colonic epitheliumUBERON:000039765.54silver quality
vermiform appendixUBERON:000115463.32gold quality
right uterine tubeUBERON:000130262.68gold quality
left ovaryUBERON:000211960.44gold quality
lymph nodeUBERON:000002960.37gold quality
mucosa of transverse colonUBERON:000499160.11gold quality
ovaryUBERON:000099259.50gold quality
spleenUBERON:000210658.93gold quality
caecumUBERON:000115358.28gold quality
right ovaryUBERON:000211858.25gold quality
smooth muscle tissueUBERON:000113558.21gold quality
rectumUBERON:000105257.46gold quality
ileal mucosaUBERON:000033157.27silver quality
corpus epididymisUBERON:000435956.57gold quality
bloodUBERON:000017856.24gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no1.17

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 18)

  • TMPO-AS1 contributes to lung carcinogenesis, which may be partially through upregulation TMPO. (PMID:31230752)
  • TMPO-AS1 is closely associated with the estrogen signaling pathway. TMPO-AS1 could positively regulate estrogen receptor 1 (ESR1) mRNA expression by stabilizing ESR1 mRNA through interaction with ESR1 mRNA. (PMID:31501276)
  • LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. (PMID:31680323)
  • Overexpression and Clinicopathological Correlation of Long Noncoding RNA TMPO-AS1 in Colorectal Cancer Patients. (PMID:31768869)
  • LncRNA TMPO-AS1 up-regulates the expression of HIF-1alpha and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. (PMID:32139259)
  • Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells. (PMID:32497621)
  • LncRNA TMPO-AS1 promotes LCN2 transcriptional activity and exerts oncogenic functions in ovarian cancer. (PMID:32692467)
  • Inhibition of lncRNA TMPOAS1 suppresses proliferation, migration and invasion of colorectal cancer cells by targeting miR1433p. (PMID:32945436)
  • LncRNA TMPO-AS1 promotes proliferation and migration in bladder cancer. (PMID:32964962)
  • LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p. (PMID:32969763)
  • LncRNA-TMPO-AS1 promotes apoptosis of osteosarcoma cells by targeting miR-329 and regulating E2F1. (PMID:33215415)
  • Down-Regulation of TMPO-AS1 Induces Apoptosis in Lung Carcinoma Cells by Regulating miR-143-3p/CDK1 Axis. (PMID:33685293)
  • The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. (PMID:34096793)
  • LncRNA TMPO-AS1 suppresses the maturation of miR-335-5p to participate in polycystic ovary syndrome. (PMID:34330309)
  • lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis. (PMID:35040749)
  • LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. (PMID:35760875)
  • Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer. (PMID:38383342)
  • LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis. (PMID:39205592)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Loeys-Dietz syndrome 2